Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
adequate, announced, Biodexa, cease, consummate, dependent, enterprise, growth, Israel, MelliorII, MPI, PLC, primary, professional, rounding, shown, struggled, summary
Removed:
actively, Antidilutive, applied, applying, ASU, Atossa, ATRX, attempt, biotech, calculation, call, Cequent, clarify, compensate, continued, corporation, creditor, debtor, diversity, effort, eliminate, emerging, enhance, EPS, exchanged, final, forced, freestanding, Healthcare, hereinafter, higher, integral, ithena, ithenapharma, manner, marketing, MDRNA, modification, modified, modify, occurring, OTCQB, prospectively, recognize, response, restructure, satisfy, specialty, strategic, substance, Subtopic, successful, successfully, suspend, symbol, test, thereunder, viability, work
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view